MASS TORT LIEN RESOLUTION
Zantac Lien Resolution
Zantac is the popular brand name of a drug called Ranitidine, which is widely used to treat various gastrointestinal conditions such as heartburn and acid reflux. Lawsuits have been filed by Zantac users who developed cancer, thought to have been caused by a potential cancer-causing contaminant.
Zantac was first sold in the U.S. in 1983 and quickly became one of the most widely used drugs on the market. In 2019, manufacturer Sanofi announced a voluntary recall of Zantac because it contained N-Nitrosodimethylamine (NDMA), which may cause cancer in humans. Among people who have used Zantac to treat heartburn, potential injuries may include cancers of the stomach, bladder, kidney, pancreas, colon, liver, esophagus, lung, or breast. Plaintiffs in this litigation have all types of healthcare insurance and all types of healthcare liens may result from a settlement.